ID: ALA5220536

Max Phase: Preclinical

Molecular Formula: C18H20N8O

Molecular Weight: 364.41

Associated Items:

Representations

Canonical SMILES:  CC1(Cn2nc(-c3ccc4oc(N)nc4c3)c3c(N)nc(N)nc32)CCC1

Standard InChI:  InChI=1S/C18H20N8O/c1-18(5-2-6-18)8-26-15-12(14(19)23-16(20)24-15)13(25-26)9-3-4-11-10(7-9)22-17(21)27-11/h3-4,7H,2,5-6,8H2,1H3,(H2,21,22)(H4,19,20,23,24)

Standard InChI Key:  IRCGXDFJTQYSNR-UHFFFAOYSA-N

Associated Targets(Human)

mTORC1 330 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

mTORC2 162 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine/threonine-protein kinase mTOR 13850 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 364.41Molecular Weight (Monoisotopic): 364.1760AlogP: 2.57#Rotatable Bonds: 3
Polar Surface Area: 147.69Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.86CX Basic pKa: 5.78CX LogP: 2.32CX LogD: 2.31
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.50Np Likeness Score: -0.73

References

1. Oleksak P, Nepovimova E, Chrienova Z, Musilek K, Patocka J, Kuca K..  (2022)  Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021).,  238  [PMID:35688004] [10.1016/j.ejmech.2022.114498]

Source